DAA4474 |
Gene expression of TMEM91 decreases with age |
TMEM91 |
— |
skin |
Human |
|
DAA4475 |
Gene expression of KRTAP24-1 decreases with age |
KRTAP24-1 |
— |
skin |
Human |
|
DAA4476 |
Gene expression of FABP9 decreases with age |
FABP9 |
— |
skin |
Human |
|
DAA4477 |
Gene expression of MORN2 decreases with age |
MORN2 |
— |
skin |
Human |
|
DAA4478 |
Gene expression of PLA2G4B increases with age |
PLA2G4B |
— |
skin |
Human |
|
DAA2038 |
Concentration of cell free DNA increases |
— |
— |
plasma |
Human |
|
DAA849 |
telomere shortening |
— |
— |
liver |
Human |
|
DAA1973 |
5-hmC increase in cerebrellum |
— |
— |
cerebellum |
Mouse |
|
DAA989 |
telomere shortening |
— |
— |
lymphocytes |
Human |
|
DAA901 |
telomere shortening |
— |
— |
kidney |
Human |
|
DAA2055 |
Circulating miR-21 expression increases |
— |
— |
blood |
Human |
|
DAA959 |
telomere shortening |
— |
— |
naïve T cell |
Human |
|
DAA1986 |
telomere shortening |
— |
— |
leukocyte |
Human |
|
DAA2000 |
NAD(+) levels decrease with age |
— |
— |
skin |
Human |
|
DAA673 |
telomere length in hematopoietic stem cells |
— |
— |
hematopoietic stem cells |
Human |
|
DAA1967 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase |
— |
— |
cerebellum |
Mouse |
|
DAA1966 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
— |
— |
hippocampus |
Mouse |
|
DAA2056 |
MicroRNA let-7b expression upregulated |
— |
— |
skeletal muscle |
Human |
|
DAA1211 |
blood HSP70 level increase |
— |
— |
plasma |
Human |
|
DAA2057 |
MicroRNA let-7e expression upregulated |
— |
— |
skeletal muscle |
Human |
|
DAA1065 |
efflux pump activity decreases |
— |
— |
blood brain barrier |
Human |
|
DAA1998 |
Lipid oxidation increased with age in males |
— |
— |
skin |
Human |
|
DAA1946 |
vitamin E levels decrease |
— |
— |
blood |
Mouse |
|
DAA1997 |
DNA damage increases with age |
— |
— |
skin |
Human |
|
DAA1067 |
transporter activity decreases |
— |
— |
blood brain barrier |
Human |
|